preprovasoactive intestinal peptide (111-122)(123025-94-5)
- Name: preprovasoactive intestinal peptide (111-122)
- Synonyms:L-Valine,N-[1-[N-[1-[N-[N-[N-[N-[N2-[N-(N-L-valyl-L-seryl)-L-seryl]-L-asparaginyl]-L-isoleucyl]-L-seryl]-L-a-glutamyl]-L-a-aspartyl]-L-prolyl]-L-valyl]-L-prolyl]-;267: PN: WO0069900 SEQID: 449 unclaimed sequence; 368: PN: US20090175821 SEQID:449 claimed protein
- Molecular Formula:C53H87 N13 O21
- Molecular Weight:1242.33238
- CAS Registry Number:123025-94-5
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 80930-71-8/N-Methyl-N-(phenylmethyl)-1,1,1-triphenylsilanamine
- 101858-42-8/b-D-Xylopyranoside, (3b,6a,16b,20R,24S)-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostane-3,6-diyl bis-
- 73772-34-6/N-(3-dimethylaminopropyl)-1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-N-[2 -[2-(2-hydroxyethoxy)ethoxy]ethyl]hexane-1-sulfonamide
- 123013-22-9/[(8S,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-methoxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
- 2468-81-7/Methylene, diazo-(7CI,8CI,9CI)
- 99924-53-5/3-(C12,14 alkoxy)-2-hydroxypropyl, phosphoric acid, N,N-dimethylaminopropylamine, alpha-C12-15 alkyl-omega-hydroxypoly(oxy-1,2-ethanediyl) amide ester
- 19913-01-0/Futoenone
- 45173-37-3/N,N,N',N'-TETRAALLYLETHYLENEDIAMINE
- 53-38-3/(1R,3aS,3bR,5aS,7R,8aS,8bS,10aS)-1-ethynyl-7,8a,10a-trimethylhexadecahydrodicyclopenta[a,f]naphthalene-1,7-diol
- 84255-21-0/2-ETHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID
- 72183-95-0/Trichadonic acid
- 71381-73-2/1-Sarcosyl-7-N-methylalanyl-8-isoleucine angiotensin II
- 22785-18-8/(6aS,6bS,10R,10aR,11aS,11bR)-10,11b-dimethyl-5,6,6a,6b,7,8,10a,11,11a,11b-decahydro-1H-benzo[a]fluorene-3,9(2H,10H)-dione
- 24303-47-7/(methylamino)({[(1Z)-1-(3-nitrophenyl)ethylidene]amino}oxy)methanone
- 72207-77-3/Iron, complexes with diazotized 5-amino-2-(phenylamino)benzenesulfonic acid monosodium salt coupled with 4-[(2-hydroxy-3,5-dinitrophenyl)azo]-1,3-benzenediol, diazotized 4-nitrobenzenamine and diazotized 3-aminobenzenesulfonic acid monosodium salt
- 27108-42-5/(aminooxy)(methylamino)methanone hydrochloride (1:1)
- 95897-98-6/N-(1-carboethoxylpropen-1-y-2)daunorubicin
- 18623-44-4/4-[5-(3,4-DIMETHOXY-BENZYLIDENE)-4-OXO-2-THIOXO-THIAZOLIDIN-3-YL]-BUTYRIC ACID
- 169238-48-6/8H-Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizin-8-one,5,6,13,13a-tetrahydro-13-hydroxy-9,10-dimethoxy-13-[(5,8,13,13a-tetrahydro-13,13a-dihydroxy-9,10-dimethoxy-6H-benzo[g]-1,3-benzodioxolo[5,6-a]quinolizin-8-yl)oxy]-(9CI)
- 123025-94-5/preprovasoactive intestinal peptide (111-122)
- 66944-59-0/piperazine-1,4-diyldiethane-2,1-diyl dicycloheptanecarboxylate dihydrochloride
- 37929-28-5/1-Butyl-3,4-dihydro-4,4,6-trimethyl-2(1H)-pyrimidinethione
- 29044-69-7/phenyl-N-methyl-N-benzylcarbamate
- 4386-42-9/2-hydroxy-3-methoxy-5-methylbenzoic acid
- 110933-35-2/Benz[a]anthracene-7,12-dimethanol,7-(hydrogen sulfate), sodium salt (1:1)
- 37744-80-2/S-[2-(butylamino)-2-oxoethyl] O,O-diethyl phosphorodithioate
- 63957-33-5/1-[4-(pentyloxy)phenyl]-3-(piperidin-1-yl)propan-1-one hydrochloride (1:1)
- 144119-83-5/vasoactive intestinal peptide (1-11)
- 490-49-3/(-)-FISETINIDOL
- 50412-82-3/2-{[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1H-1,2,4-triazol-3-yl]sulfanyl}acetohydrazide